SUNIE THOMAS: Open Payments
NPI 1669109039 · SAINT GEORGE, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,015 in 59 payments from 15 companies in 2025. Trend: 2023 $482 · 2024 $594 · 2025 $1,015
Food & beverage: $1,015
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 10 | $205 |
| Teva Pharmaceuticals USA, Inc. | 14 | $199 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 9 | $135 |
| ABBVIE INC. | 5 | $90 |
| Biogen, Inc. | 4 | $72 |
| Janssen Pharmaceuticals, Inc | 3 | $66 |
| Collegium Pharmaceutical, Inc. | 3 | $63 |
| E.R. Squibb & Sons, L.L.C. | 3 | $46 |
| Alkermes, Inc. | 2 | $29 |
| Axsome Therapeutics, Inc. | 1 | $26 |
Products named: UZEDY, CAPLYTA, REXULTI, VRAYLAR, ABILIFY MAINTENA, ZURZUVAE, SPRAVATO, Jornay PM.
Industry payments across UT — which companies pay providers there.
